Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Routine imaging for diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is controversial and plays a limited role in detecting relapse. This population-based study compared the survival of Danish and Swedish patients with DLBCL for whom traditions for routine imaging have been different.

Detaljer

Författare
  • Tarec Christoffer El-Galaly
  • Lasse Hjort Jakobsen
  • Martin Hutchings
  • Peter de Nully Brown
  • Herman Nilsson-Ehle
  • Erzsébet Szekely
  • Karen Juul Mylam
  • Viktoria Hjalmar
  • Hans Erik Johnsen
  • Martin Bøgsted
  • Mats Jerkeman
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Cancer och onkologi
Originalspråkengelska
Sidor (från-till)3993-3998
TidskriftJournal of Clinical Oncology
Volym33
Utgivningsnummer34
StatusPublished - 2015
PublikationskategoriForskning
Peer review utfördJa